RJ Novick, J MacDonald, RA Veldhuizen, F Wan, J Duplan, L Denning, F Possmayer, AA Gilpin, LJ Yao, D Bjarneson and JF Lewis
Transplantation-Immunobiology Group, Robarts Research Institute, University Hospital, London, Ontario, Canada.

We have previously documented alterations in endogenous surfactant after lung transplantation and improved graft function in some dogs after instillation of bovine lipid extract surfactant (bLES) into the recipient. To determine the effect of bLES delivery method and timing of treatment on physiologic response and surfactant recovery, 21 canine left lung grafts were divided into four groups: (1) Treatment of the donor for 3 h with aerosolized bLES prior to graft storage (Donor Aerosol); (2) Treatment of the recipient with instilled bLES immediately after transplantation (Recipient Instilled); (3) No bLES treatment (Control); and (4) Aerosolized bLES in donors and instilled bLES in recipients (Combined Therapy). Aerosolized bLES was labeled with [3H]-dipalmitoylphosphatidylcholine (DPPC) and instilled bLES with [14C]-DPPC. Grafts were stored for 36 h, transplanted and reperfused for 6 h. The native right and transplanted left lungs were then lavaged and protein yield, surfactant aggregates, and bLES recovery were measured. After 6 h of reperfusion, PO2/FlO2 ratio was significantly better after Combined Therapy (372 +/- 52 mm Hg) than in the Recipient Instilled (117 +/- 47 mm Hg) and Control groups (87 +/- 26 mm Hg), with intermediate values in Donor Aerosol dogs (232 +/- 64 mm Hg). The recovery of donor aerosolized bLES from transplanted lungs was increased in dogs given Combined Therapy versus Donor Aerosol treatment alone (p = 0.03). Furthermore, with Combined Therapy there was an increased percentage of instilled bLES recovered from transplanted lungs compared with the Recipient Instilled group. We conclude that surfactant treatment strategies influence physiologic response and bLES recovery after prolonged lung preservation. Treatment of lung donors with exogenous surfactant prior to graft storage was associated with less severe lung injury. Combined donor and recipient bLES therapy resulted in a superior physiologic response during reperfusion in this model.

This article has been cited by other articles:

				M. Struber, S. Fischer, J. Niedermeyer, G. Warnecke, B. Gohrbandt, A. Gorler, A. R. Simon, A. Haverich, and J. M. Hohlfeld Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1620 - 1625. [Abstract] [Full Text] [PDF]

				I. Friedrich, J. Borgermann, F. H. Splittgerber, M. Brinkmann, J. C. Reidemeister, R. E. Silber, W. Seeger, R. Schmidt, and A. Gunther Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 335 - 343. [Abstract] [Full Text] [PDF]

				A. Gunther, M. Balser, R. Schmidt, P. Markart, A. Olk, J. Borgermann, F. H. Splittgerber, W. Seeger, and I. Friedrich Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 344 - 354. [Abstract] [Full Text] [PDF]

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]

				R. J. Novick Innovative techniques to enhance lung preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 3 - 5. [Full Text] [PDF]

				M. Struber, J. M. Hohlfeld, T. Kofidis, G. Warnecke, J. Niedermeyer, S. P. Sommer, and A. Haverich Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 98 - 103. [Abstract] [Full Text] [PDF]

				G. Maitra, K. Inchley, R. J. Novick, R. A. W. Veldhuizen, J. F. Lewis, and F. Possmayer Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L67 - L74. [Abstract] [Full Text] [PDF]

				M. Struber, M. Wilhelmi, W. Harringer, J. Niedermeyer, M. Anssar, A. Kunsebeck, J. D. Schmitto, and A. Haverich Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 190 - 194. [Abstract] [Full Text] [PDF]

				M. Struber, J. M. Hohlfeld, S. Fraund, P. Kim, G. Warnecke, and A. Haverich Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 566 - 572. [Abstract] [Full Text] [PDF]

				M. OCHS, I. NENADIC, A. FEHRENBACH, J. M. ALBES, T. WAHLERS, J. RICHTER, and H. FEHRENBACH Ultrastructural Alterations in Intraalveolar Surfactant Subtypes after Experimental Ischemia and Reperfusion Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 718 - 724. [Abstract] [Full Text]

				M. E. ERASMUS, G. J. H. HOFSTEDE, A. H. PETERSEN, H. P. HAAGSMAN, S. B. OETOMO, and J. PROP Effects of Early Surfactant Treatment Persisting for One Week after Lung Transplantation in Rats Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 567 - 572. [Abstract] [Full Text]

				R. C. King, O. A. R. Binns, R. C. Kanithanon, J. T. Cope, R. L. Chun, K. S. Shockey, C. G. Tribble, and I. L. Kron Low-Dose Sodium Nitroprusside Reduces Pulmonary Reperfusion Injury Ann. Thorac. Surg., May 1, 1997; 63(5): 1398 - 1404. [Abstract] [Full Text]

				R. J. Novick, A. A. Gilpin, K. E. Gehman, I. S. Ali, R. A. W. Veldhuizen, J. Duplan, L. Denning, F. Possmayer, D. Bjarneson, and J. F. Lewis MITIGATION OF INJURY IN CANINE LUNG GRAFTS BY EXOGENOUS SURFACTANT THERAPY J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 342 - 353. [Abstract] [Full Text]